keyword
https://read.qxmd.com/read/38657290/clinical-factors-associated-with-unexpected-poor-or-suboptimal-response-in-poseidon-criteria-patients
#1
JOURNAL ARTICLE
Alyssa Hochberg, Michael H Dahan, Hakan Yarali, Lan N Vuong, Sandro C Esteves
RESEARCH QUESTION: What clinical factors are associated with 'unexpected' poor or suboptimal responses to IVF ovarian stimulation per POSEIDON's criteria, and which AMH and AFC threshold values distinguish this population? DESIGN: Tri-centre retrospective cohort study (2015-2017) involving first-time IVF and ICSI cycles with conventional ovarian stimulation (≥150 IU/day of FSH). Eligibility criteria included sufficient ovarian reserve markers according to POSEIDON's classification (AMH ≥1...
January 30, 2024: Reproductive Biomedicine Online
https://read.qxmd.com/read/38657266/membrane-fusion-liposomes-deliver-antifibrotic-and-chemotherapeutic-drugs-sequentially-to-enhance-tumor-treatment-efficacy-by-reshaping-tumor-microenvironment
#2
JOURNAL ARTICLE
Nan Jia, Qi Wang, Wenpan Li, Dawei Chen, Haiyang Hu
The intricate tumor microenvironment in triple-negative breast cancer (TNBC) hampers chemotherapy and immunotherapy efficacy due to dense extracellular matrix (ECM) by tumor-associated fibroblasts (TAFs). Nanoparticle-based therapies, especially "all in one" nanoparticles, have shown great potential in combined drug delivery strategies to reshape the tumor microenvironment and enhance therapeutic efficiency. However, these "all in one" nanoparticles suffer from limitations in targeting different target cells, uncontrollable dosing ratio, and disregarding the impact of delivery schedules...
April 24, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38657233/first-in-human-stage-iii-iv-melanoma%C3%A2-clinical-trial-of-immune-priming-agent-ifx-hu2-0
#3
JOURNAL ARTICLE
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Delhawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari Pilon-Thomas
IFx-Hu2.0 was designed to encode part of the Emm55 protein contained within a plasmid in a formulation intended for transfection into mammalian cells. IFx-Hu2.0 promotes both adaptive and innate immune responses in animal studies. Furthermore, previous studies have demonstrated safety/efficacy in equine, canine, and murine species. We present the first-in-human study of IFx-Hu2.0, administered by intralesional injection into melanoma tumors of seven patients with stage III/IV unresectable melanoma. No dose-limiting toxicities attributable to IFx-Hu2...
April 24, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38657216/effect-of-antimicrobial-agent-coating-on-physicochemical-and-biologic-properties-of-implant-abutments-a-systematic-review
#4
JOURNAL ARTICLE
Murilo Rodrigues de Campos, Andréa Cândido Dos Reis
PURPOSE: To analyze the effectiveness of coating of abutments with antimicrobial agents and their influence on the physicochemical and biologic properties of the coated materials. MATERIALS AND METHODS: This work was registered in Open Science Framework (osf.io/6tkcp) and followed the PRISMA protocols. A search of two independent reviewers of articles published up to October 29, 2021, was performed in the Embase, PubMed, Science Direct, and Scopus databases. RESULTS: The databases found a total of 1,474 references...
April 24, 2024: International Journal of Oral & Maxillofacial Implants
https://read.qxmd.com/read/38657203/design-and-synthesis-of-phenoxy-methyl-oxadiazole-compounds-against-alzheimer-s-disease
#5
JOURNAL ARTICLE
Asaf E Evren, Demokrat Nuha, Begüm N S Özkan, Çiğdem Kahraman, Ekrem M Gönülalan, Leyla Yurttaş
This study examines the synthesis and evaluation of 11 newly developed compounds as potential anti-Alzheimer's agents that occur via cholinesterase and β-secretase inhibition. The compounds were tested for their inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using the modified Ellman method. The results showed that several compounds exhibited significant inhibition of AChE, particularly compounds 6d, 7a, and 7e, which demonstrated high inhibitory activity at lower concentrations, with IC50 values of 0...
April 24, 2024: Archiv der Pharmazie
https://read.qxmd.com/read/38657187/-nectin4-amplification-is-frequent-in-solid-tumors-and-predicts-enfortumab-vedotin-response-in-metastatic-urothelial-cancer
#6
JOURNAL ARTICLE
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Günter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Jörg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua Meeks, Francisco E Vera Badillo, J Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Grünwald, Michael Hölzel, Markus Eckstein
PURPOSE: The anti-NECTIN4 antibody-drug conjugate enfortumab vedotin (EV) is approved for patients with metastatic urothelial cancer (mUC). However, durable benefit is only achieved in a small, yet uncharacterized patient subset. NECTIN4 is located on chromosome 1q23.3, and 1q23.3 gains represent frequent copy number variations (CNVs) in urothelial cancer. Here, we aimed to evaluate NECTIN4 amplifications as a genomic biomarker to predict EV response in patients with mUC. MATERIALS AND METHODS: We established a NECTIN4 -specific fluorescence in situ hybridization (FISH) assay to assess the predictive value of NECTIN4 CNVs in a multicenter EV-treated mUC patient cohort (mUC-EV, n = 108)...
April 24, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38657185/phenotypic-insights-into-anti-iglon5-disease-in-iglon5-deficient-mice
#7
JOURNAL ARTICLE
Sin Yi Lee, Hirotaka Shoji, Aki Shimozawa, Hirofumi Aoyagi, Yoshiaki Sato, Kazuya Tsumagari, Mika Terumitsu, Haruhiko Motegi, Kensuke Okada, Koji Sekiguchi, Junro Kuromitsu, Jin Nakahara, Tsuyoshi Miyakawa, Daisuke Ito
BACKGROUND AND OBJECTIVES: Anti-IgLON5 disease is an autoimmune neurodegenerative disorder characterized by various phenotypes, notably sleep and movement disorders and tau pathology. Although the disease is known to be associated with the neuronal cell adhesion protein IgLON5, the physiologic function of IgLON5 remains elusive. There are conflicting views on whether autoantibodies cause loss of function, activation of IgLON5, or inflammation-associated neuronal damage, ultimately leading to the disease...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38657120/il1r2-blockade-alleviates-immunosuppression-and-potentiates-anti-pd-1-efficacy-in-triple-negative-breast-cancer
#8
JOURNAL ARTICLE
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guohong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Interleukin-1 receptor type 2 (IL1R2) promotes breast tumor-initiating cell (BTIC) self-renewal and tumor growth in TNBC, indicating that targeting it could improve patient treatment. Here, we observed that IL1R2 blockade strongly attenuated macrophage recruitment and the polarization of tumor-associated macrophages (TAMs) to inhibit BTIC self-renewal and CD8+ T cell exhaustion, which resulted in reduced tumor burden and prolonged survival in TNBC mouse models...
April 24, 2024: Cancer Research
https://read.qxmd.com/read/38657003/immunomodulatory-peptides-for-tumor-treatment
#9
REVIEW
Yang Song, Longtianyang Lei, Xingyu Cai, Hua Wei, Cui-Yun Yu
Peptides exhibit various biological activities, including biorecognition, cell targeting, and tumor penetration, and can stimulate immune cells to elicit immune responses for tumor immunotherapy. Peptide self-assemblies and peptide-functionalized nanocarriers can reduce the effect of various biological barriers and the degradation by peptidases, enhancing the efficiency of peptide delivery and improving anti-tumor immune responses. To date, the design and development of peptides with various functionalities have been extensively reviewed for enhanced chemotherapy; however, peptide-mediated tumor immunotherapy using peptides acting on different immune cells, to the knowledge, has not yet been summarized...
April 24, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38656972/tesofensine-a-novel-antiobesity-drug-silences-gabaergic-hypothalamic-neurons
#10
JOURNAL ARTICLE
Claudia I Perez, Jorge Luis-Islas, Axel Lopez, Xarenny Diaz, Omar Molina, Benjamin Arroyo, Mario G Moreno, Elvi Gil Lievana, Esmeralda Fonseca, Gilberto Castañeda-Hernández, Ranier Gutierrez
Obesity is a major global health epidemic that has adverse effects on both the people affected as well as the cost to society. Several anti-obesity drugs that target GLP-1 receptors have recently come to the market. Here, we describe the effects of tesofensine, a novel anti-obesity drug that acts as a triple monoamine neurotransmitter reuptake inhibitor. Using various techniques, we investigated its effects on weight loss and underlying neuronal mechanisms in mice and rats. These include behavioral tasks, DeepLabCut videotaped analysis, electrophysiological ensemble recordings, optogenetic activation, and chemogenetic silencing of GABAergic neurons in the Lateral Hypothalamus (LH)...
2024: PloS One
https://read.qxmd.com/read/38656971/gut-microbiota-composition-in-patients-with-crohn-s-disease-in-saudi-arabia
#11
JOURNAL ARTICLE
Hadil Alahdal, Ghaida Almuneef, Manal Muhammed Alkhulaifi, Omar Aldibasi, Abdulrahman Aljouie, Othman Alharbi, Zakiah Naser Almohawes, Fatemah Basingab, Mokhtar Rejili
Crohn's disease (CD) entails intricate interactions with gut microbiome diversity, richness, and composition. The relationship between CD and gut microbiome is not clearly understood and has not been previously characterized in Saudi Arabia. We performed statistical analysis about various factors influencing CD activity and microbiota dysbiosis, including diagnosis, treatment, and its impact on their quality of life as well as high-throughput metagenomic V3-V4 16S rRNA encoding gene hypervariable region of a total of eighty patients with CD, both in its active and inactive state with healthy controls...
2024: PloS One
https://read.qxmd.com/read/38656957/a-point-of-care-testing-assay-for-clonorchiasis-using-a-eunps-cstr1-fluorescent-probe-based-immunoassay
#12
JOURNAL ARTICLE
Xiaoxiao Ma, Huiyuan Zhang, Yiming Fang, Jing Wang, Xingyang Wang, Chen Li, Xiaolei Liu, Mingyuan Liu, Bin Tang, Yi Liu
Clonorchis sinensis is one of the most important fish-borne zoonotic parasitic worms in humans, and is distributed in several countries with more than 15 million people infected globally. However, the lack of a point-of-care testing (POCT) method is still the critical barrier to effectively prevent clonorchiasis. With the application of novel fluorescent nanomaterials, the development of on-site testing methods with high signal enhancement can provide a simple, precise and inexpensive tool for disease detection...
April 24, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38656953/health-care-is-the-new-battlefront-for-anti-dei-attacks
#13
JOURNAL ARTICLE
Oni J Blackstock, Jessica E Isom, Rupinder K Legha
No abstract text is available yet for this article.
2024: PLOS Glob Public Health
https://read.qxmd.com/read/38656927/a-new-xanthone-isolated-from-garcinia-bracteata-and-its-important-effect-on-no-levels
#14
JOURNAL ARTICLE
Changfen Li, Qiao Wang, Yanjiao Liu, Binbin Liao, Xinjian Zhang, Lingling Chen, Jianying Zhang, Hongyun Wang, Aixue Zuo
A new xanthone, allanxanthone F ( 1 ), and 10 known compounds were isolated from the ethanol extract of Garcinia bracteata . The structure of compound 1 was elucidated based on spectroscopic methods (UV, IR, HR-ESI-MS, and NMR). In addition, compounds 1 - 9 were assessed for their anti-inflammatory activities based on the expression of nitric oxide (NO) levels on lipopolysaccharide (LPS)-induced RAW264.7 macrophages, and compounds 1 - 3 , 4 and 6-9 suggested potential anti-inflammatory activities.
April 24, 2024: Natural Product Research
https://read.qxmd.com/read/38656916/elucidating-the-anti-obesity-potential-of-bioactive-fractions-of-kalanchoe-pinnata-lam-leaves-extract-using-a-combination-of-in-vitro-in-vivo-and-in-silico-methods-along-with-characterisation-of-lead-compounds-through-an-hptlc-ms-ms-n-analytical-study
#15
JOURNAL ARTICLE
Ravi Pratap Singh, Ashok Kumar Pattnaik
Fractions were isolated from the leaves extract of Kalanchoe pinnata and subjected to scrutiny for their prospective anti-obesity properties. An array of preliminar y phytochemical, invitro antioxidant, and enzyme inhibition assays were executed, which discerned fractions F1 and F2 as the most effective fractions. These fractions were subsequently studied through invivo experiments, affirming that F2 as the most potent fraction. Further characterisation of F2 was conducted via HPTLC-Mass spectrometry (MS-MSn ) techniques...
April 24, 2024: Natural Product Research
https://read.qxmd.com/read/38656897/-actinidia-arguta-extract-containing-myo-inositol-suppresses-tnf-%C3%AE-induced-vcam-1-expression-and-monocyte-adhesion-to-endothelial-cells-via-inhibition-of-the-pten-akt-gsk-3-%C3%AE-and-nf-%C3%AE%C2%BA-b-signaling-pathways
#16
JOURNAL ARTICLE
Jangho Lee, Joon Park, Kyung-Mo Song, Yu Geon Lee, Hyo-Kyoung Choi
The primary inflammatory process in atherosclerosis, a major contributor to cardiovascular disease, begins with monocyte adhering to vascular endothelial cells. Actinidia arguta (kiwiberry) is an edible fruit that contains various bioactive components. While A. arguta extract (AAE) has been recognized for its anti-inflammatory characteristics, its specific inhibitory effect on early atherogenic events has not been clarified. We used tumor necrosis factor- α (TNF- α )-stimulated human umbilical vein endothelial cells (HUVECs) for an in vitro model...
April 24, 2024: Journal of Medicinal Food
https://read.qxmd.com/read/38656895/reactive-oxygen-species-responsive-dual-anti-inflammatory-and-antioxidative-nanoparticles-for-anterior-uveitis
#17
JOURNAL ARTICLE
Dike Zhang, Jian He, Shi Yuan Hua, Yonghua Li, Min Zhou
Anterior uveitis (AU) is an immune-mediated inflammatory disease that results in iritis, cyclitis, glaucoma, cataracts, and even a loss of vision. The frequent and long-term administration of corticosteroid drugs is limited in the clinic owing to the side effects and patient noncompliance with the drugs. Therefore, specifically delivering drugs to inflammatory anterior segment tissues and reducing the topical application dosage of the drug are still a challenge. Here, we developed dual dexamethasone (Dex) and curcumin (Cur)-loaded reactive oxygen species (ROS)-responsive nanoparticles (CPDC NPs) to treat anterior uveitis...
April 24, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38656874/prophylactic-treatment-with-the-c-abl-inhibitor-neurotinib-diminishes-neuronal-damage-and-the-convulsive-state-in-pilocarpine-induced-mice
#18
JOURNAL ARTICLE
América Chandía-Cristi, Daniela A Gutiérrez, Andrés E Dulcey, Marcelo Lara, Lina Vargas, Yi-Han Lin, Pablo Jimenez-Muñoz, Gabriela Larenas, Xin Xu, Amy Wang, Ashley Owens, Christopher Dextras, YuChi Chen, Claudio Pinto, Tamara Marín, Hugo Almarza-Salazar, Keryma Acevedo, Gonzalo I Cancino, Xin Hu, Patricio Rojas, Marc Ferrer, Noel Southall, Mark J Henderson, Silvana Zanlungo, Juan J Marugan, Alejandra Álvarez R
The molecular mechanisms underlying seizure generation remain elusive, yet they are crucial for developing effective treatments for epilepsy. The current study shows that inhibiting c-Abl tyrosine kinase prevents apoptosis, reduces dendritic spine loss, and maintains N-methyl-d-aspartate (NMDA) receptor subunit 2B (NR2B) phosphorylated in in vitro models of excitotoxicity. Pilocarpine-induced status epilepticus (SE) in mice promotes c-Abl phosphorylation, and disrupting c-Abl activity leads to fewer seizures, increases latency toward SE, and improved animal survival...
April 23, 2024: Cell Reports
https://read.qxmd.com/read/38656869/batf3-dcs-and-the-4-1bb-4-1bbl-axis-are-required-at-the-effector-phase-in-the-tumor-microenvironment-for-pd-1-pd-l1-blockade-efficacy
#19
JOURNAL ARTICLE
Andrea Ziblat, Brendan L Horton, Emily F Higgs, Ken Hatogai, Anna Martinez, Jason W Shapiro, Danny E C Kim, YuanYuan Zha, Randy F Sweis, Thomas F Gajewski
The cellular source of positive signals that reinvigorate T cells within the tumor microenvironment (TME) for the therapeutic efficacy of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade has not been clearly defined. We now show that Batf3-lineage dendritic cells (DCs) are essential in this process. Flow cytometric analysis, gene-targeted mice, and blocking antibody studies revealed that 4-1BBL is a major positive co-stimulatory signal provided by these DCs within the TME that translates to CD8+ T cell functional reinvigoration and tumor regression...
April 23, 2024: Cell Reports
https://read.qxmd.com/read/38656754/teicoplanin-decorated-reduced-graphene-oxide-incorporated-silk-protein-hybrid-hydrogel-for-accelerating-infectious-diabetic-wound-healing-and-preventing-diabetic-foot-osteomyelitis
#20
JOURNAL ARTICLE
Bianza Moise Bakadia, Ruizhu Zheng, Abeer Ahmed Qaed Ahmed, Zhijun Shi, Bakamona Lina Babidi, Sun Tun, Ying Li, Guang Yang
Developing hybrid hydrogel dressings with anti-inflammatory, antioxidant, angiogenetic, and antibiofilm activities with higher bone tissue penetrability to accelerate diabetic wound healing and prevent diabetic foot osteomyelitis (DFO) is highly desirable in managing diabetic wounds. Herein, the glycopeptide teicoplanin is used for the first time as a green reductant to chemically reduce graphene oxide (GO). The resulting teicoplanin-decorated reduced graphene oxide (rGO) is incorporated into a mixture of silk proteins (SP) and crosslinked with genipin to yield a physicochemically crosslinked rGO-SP hybrid hydrogel...
April 24, 2024: Advanced Healthcare Materials
keyword
keyword
55411
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.